News

Vaccine Safety

Kimberly Redmond | Equities.com |

Most unvaccinated Americans say they do not want to take Johnson & Johnson’s COVID-19 vaccine, according to a newly-released poll taken when the single-shot dose was paused amid concerns over its safety.

An ABC News/Washington Post survey released Monday showed that 73% of those yet to be vaccinated said they would not take J&J’s vaccine, while only 22% said they would.


AP News | Equities.com |

A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots. Out of nearly 8 million people vaccinated before the U.S. suspended J&J’s shot, health officials uncovered 15 cases of a highly unusual kind of blood clot, three of them fatal. All were women, most younger than 50. But advisers to the Centers for Disease Control and Prevention said Friday the vaccine’s benefits outweigh that serious but small risk -- especially against a virus that’s still infecting tens of thousands of Americans every day. The government will rapidly weigh that recommendation in deciding next steps.